Advanced search×

Mortality associated with cefepime therapy among neutropenic patients.

Lucia Gomez, Salvador Quintana, and Javier Garau

Clin Infect Dis 49(6):987 (2009) PMID 19694538

DOI: 10.1086/605535
Version: za2963e q8za9 q8zbd q8zc5 q8zdf q8zed q8zfb q8zgf

Similar articles you may find interesting…

  1. Antibiotic management of febrile neutropenia: current developments and future directions.
    J J Mebis, H H Goossens, and Z N ZN Berneman

    J Chemother 22(1):5-12 (2010) PMID 20227985

    Mortality due to febrile neutropenia has decreased since the concept of empiric therapy became standard care. However, infectious complications remain the most common adverse events of chemotherapy. bacterial epidemiology has changed during the past decades. There is currently an increasing trend in...
  2. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary respons...
    A A Figuera, J F JF Tomás, ... J M JM Fernández-Rañada

    Rev Clin Esp 196(8):515-22 (1996) PMID 8984537

    The results of empiric antibiotic therapy in 126 episodes of febrile neutropenia in patients with hematologic neoplasms postchemotherapy and bone marrow transplantation are presented. The main objective of this work was the study of the initial control of infection comparing two glycopeptidic antibi...
  3. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Resear...
    Author(s) unavailable

    J Infect Dis 163(5):951-8 (1991) PMID 2019772

    These results do not support the empirical addition of vancomycin to initial antibiotic therapy in cancer patients with fever and granulocytopenia....